DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1404
BEXATAMIG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
BEXATAMIG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROSNILIMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ROSNILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ICM3
2
Antibody
Investigational
Unknown
Unknown
Unknown
Intercellular adhesion molecule 3 inhibitor
ICM3
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEDI-6469
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Lymphoma; Prostatic Neoplasms; Melanoma
Tumor necrosis factor receptor superfamily member 4 agonist
MEDI-6469
×
Maximum Phase:
2
First Approval:
None
UNII:
AKV2GM43DD
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAXITAMAB
2
Antibody
Investigational
Unknown
Unknown
Neuroblastoma
Disialoganglioside GD2 binding agent
NAXITAMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
9K8GNJ2874
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BICIROMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
BICIROMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASELIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Leukocyte adhesion molecule-1 inhibitor
ASELIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y539D78FU
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VOPIKITUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
VOPIKITUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BLESELUMAB
2
Antibody
Investigational
Unknown
Unknown
Glomerulosclerosis, Focal Segmental; Psoriasis
Tumor necrosis factor receptor superfamily member 5 inhibitor
BLESELUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AS3AZ5R46K
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEIHULIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Psoriasis
P-selectin glycoprotein ligand 1 inhibitor
NEIHULIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
615637S5PE
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AR-20.5
2
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
AR-20.5
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DENINTUZUMAB MAFODOTIN
2
Antibody
Investigational
Unknown
Unknown
Burkitt Lymphoma; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse
B-lymphocyte antigen CD19 binding agent
DENINTUZUMAB MAFODOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
H5324S1M7H
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEBTELOVIMAB
2
Antibody
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
BEBTELOVIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALETEKITUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ALETEKITUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELEZANUMAB
2
Antibody
Investigational
Unknown
Unknown
Ischemic Stroke; Multiple Sclerosis; Spinal Cord Injuries
Repulsive guidance molecule A inhibitor
ELEZANUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
SK1LVT23A1
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BATOCLIMAB
2
Antibody
Investigational
Unknown
Unknown
Anemia, Hemolytic, Autoimmune; Graves Ophthalmopathy; Myasthenia Gravis; Purpura, Thrombocytopenic, Idiopathic
IgG receptor FcRn large subunit p51 inhibitor
BATOCLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
C98V9UMX3D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FIRASTOTUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
FIRASTOTUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODINE I 131 DERLOTUXIMAB BIOTIN
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
IODINE I 131 DERLOTUXIMAB BIOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SUVRATOXUMAB
2
Antibody
Investigational
Unknown
Unknown
Staphylococcal Infections; Pneumonia, Staphylococcal
Alpha-hemolysin inhibitor
SUVRATOXUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
4L1997J4DF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTEGOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome
Unknown
ASTEGOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
27TW751DTH
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCESTOBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ALCESTOBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOMAGROZUMAB
2
Antibody
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Growth/differentiation factor 8 inhibitor
DOMAGROZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
516MD5WQ24
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALPURBATUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
CALPURBATUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VOBRAMITAMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
VOBRAMITAMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOTEVTAMAB
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
SOTEVTAMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMSIDOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Acneiform Eruptions; Acne Vulgaris; Hidradenitis Suppurativa; Ichthyosis; Psoriasis
IL36 receptor antagonist
IMSIDOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOSAKITUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
BOSAKITUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUMISTOBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
LUMISTOBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OGALVIBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
OGALVIBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INCAGN01876
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
INCAGN01876
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CUSATUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute
CD70 antigen inhibitor
CUSATUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
RR5U4UFJ8L
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZADOPRUBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ZADOPRUBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMALUMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Macrophage migration inhibitory factor inhibitor
IMALUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
22F97PC79G
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RESUGOSBART
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
RESUGOSBART
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADAKITUG
2
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
ADAKITUG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
30
31
32
33
34
35
36
…
40
41
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA